phrykt

Zoetis (ZTS) cash: $2.5B

Zoetis held $2.5B in cash and cash equivalents on Dec 31, 2025, up 23.3% from $2B a year earlier.

From Zoetis's filings with the SEC · Read the filing · ZTS stock page

Zoetis cash by year

$3.5B2021$3.6B2022$2B2023$2B2024$2.5B2025

#240 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$2.5B+23%
Dec 31, 2024$2B-3%
Dec 31, 2023$2B-43%
Dec 31, 2022$3.6B+3%
Dec 31, 2021$3.5B–

Cash of similar companies

Companies in the same industry as Zoetis, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
TEVA Pharmaceutical Industries$3.6BDec 31, 2025
Regeneron Pharmaceuticals$3.1BDec 31, 2025
Zoetis$2.5BDec 31, 2025
Alnylam Pharmaceuticals$1.7BDec 31, 2025
United Therapeutics$1.6BDec 31, 2025
Roivant Sciences$1.5BDec 31, 2025
Jazz Pharmaceuticals$1.4BDec 31, 2025

Questions and answers

What is Zoetis's cash?

Zoetis held $2.5B in cash and cash equivalents on Dec 31, 2025, up 23.3% from $2B a year earlier.

Numbers as reported in Zoetis's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology